Research / NVDA / Fundamental state Inspectable configuration
State dimensions Filing 0001045810-26-000075 General Corporate
Debt relative to revenue 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
34.68% · OPTIONAL · VALID
Capex intensity 36th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.78% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
25.02% · OPTIONAL · VALID
Revenue growth 75th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
105.85% · CORE · VALID
Inventory pressure 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
32.81% · OPTIONAL · VALID
Gross margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
74.98% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
66.24% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
7.33% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.11% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Oct 31, 2021 0/9 normalized Level 3 Jan 30, 2022 0/8 normalized Level 3 May 1, 2022 0/8 normalized Level 3 Jul 31, 2022 6/8 normalized Level 3 Oct 30, 2022 7/8 normalized Level 3 Jan 29, 2023 7/8 normalized Level 3 Apr 30, 2023 7/8 normalized Level 3 Jul 30, 2023 8/8 normalized Level 3 Oct 29, 2023 8/8 normalized Level 3 Jan 28, 2024 8/9 normalized Level 3 Apr 28, 2024 8/9 normalized Level 3 Jul 28, 2024 8/9 normalized Level 3 Oct 27, 2024 8/9 normalized Level 3 Jan 26, 2025 9/9 normalized Level 3 Apr 27, 2025 9/9 normalized Level 3 Jul 27, 2025 9/9 normalized Level 3 Oct 26, 2025 9/9 normalized Level 3 Jan 25, 2026 9/9 normalized Level 3 Apr 26, 2026 9/9 normalized Level 3 Jul 26, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 10.38%
Current 34.68%
Delta 24.30% Capex Intensity Increased
Previous 2.15%
Current 2.78%
Delta 0.63% Cash Generation Decreased
Previous 61.68%
Current 25.02%
Delta -36.66% Growth Increased
Previous 85.23%
Current 105.85%
Delta 20.62% Inventory Pressure Increased
Previous 31.61%
Current 32.81%
Delta 1.21% Margin Increased
Previous 74.93%
Current 74.98%
Delta 0.04% Profitability Increased
Previous 65.60%
Current 66.24%
Delta 0.64% R And D Intensity Decreased
Previous 7.74%
Current 7.33%
Delta -0.41% Sbc Intensity Decreased
Previous 2.36%
Current 2.11%
Delta -0.26% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Oct 26, 2025
Similarity 78%
Compared 9 dimensions
Coverage 100% Growth 27.9 · Margin 10.0 · Profitability 5.0 · Sbc Intensity 0.0 · Capex Intensity 18.8 · Cash Generation 40.0 · R And D Intensity 0.0 · Inventory Pressure 0.0 · Balance Sheet Leverage 40.0 Oct 29, 2023
Similarity 73%
Compared 8 dimensions
Coverage 89% Growth 25.0 · Margin 15.0 · Profitability 0.0 · Sbc Intensity 0.0 · Cash Generation 41.7 · R And D Intensity 0.0 · Inventory Pressure 51.9 · Balance Sheet Leverage 21.9 Apr 26, 2026
Similarity 72%
Compared 9 dimensions
Coverage 100% Growth 11.8 · Margin 0.0 · Profitability 0.0 · Sbc Intensity 0.0 · Capex Intensity 20.3 · Cash Generation 70.0 · R And D Intensity 0.0 · Inventory Pressure 20.0 · Balance Sheet Leverage 35.0 Jul 28, 2024
Similarity 67%
Compared 8 dimensions
Coverage 89% Growth 0.0 · Margin 8.8 · Profitability 6.3 · Sbc Intensity 0.0 · Cash Generation 68.3 · R And D Intensity 0.0 · Inventory Pressure 50.0 · Balance Sheet Leverage 38.8 Jan 26, 2025
Similarity 64%
Compared 9 dimensions
Coverage 100% Growth 3.6 · Margin 3.9 · Profitability 5.6 · Sbc Intensity 5.6 · Capex Intensity 1.8 · Cash Generation 63.2 · R And D Intensity 5.6 · Inventory Pressure 75.0 · Balance Sheet Leverage 45.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.